FIG 1.
Magnetic resonance images of the brain (T1 axial postcontrast series) (A) before and (B) 1 month after treatment with lorlatinib, showing significant response of all metastatic brain lesions.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.